Itau Unibanco Holding S.A. Ionis Pharmaceuticals Inc Transaction History

Itau Unibanco Holding S.A.

  • $2.95 Billion
  • Q3 2024

A detailed history of Itau Unibanco Holding S.A. transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Itau Unibanco Holding S.A. holds 1,081 shares of IONS stock, worth $39,272. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,081
Previous 767 40.94%
Holding current value
$39,272
Previous $36,000 19.44%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$40.06 - $51.86 $12,578 - $16,284
314 Added 40.94%
1,081 $43,000
Q2 2024

Aug 13, 2024
BUY
$36.45 - $47.7 $27,957 - $36,585
767 New
767 $36,000
Q4 2023

Feb 14, 2024
SELL
$43.39 - $51.63 $16,401 - $19,516
-378 Reduced 20.92%
1,429 $72,000
Q3 2023

Nov 14, 2023
SELL
$38.5 - $47.13 $308 - $377
-8 Reduced 0.44%
1,807 $81,000
Q2 2023

Aug 14, 2023
SELL
$34.73 - $43.33 $937 - $1,169
-27 Reduced 1.47%
1,815 $74,000
Q1 2023

May 12, 2023
SELL
$33.58 - $41.2 $201 - $247
-6 Reduced 0.32%
1,842 $65,000
Q4 2022

Feb 09, 2023
BUY
$37.12 - $46.52 $371 - $465
10 Added 0.54%
1,848 $69,000
Q3 2022

Nov 14, 2022
SELL
$36.54 - $48.66 $29,707 - $39,560
-813 Reduced 30.67%
1,838 $81,000
Q2 2022

Aug 15, 2022
SELL
$31.71 - $43.0 $4,439 - $6,020
-140 Reduced 5.02%
2,651 $98,000
Q1 2022

May 16, 2022
SELL
$29.88 - $37.04 $388 - $481
-13 Reduced 0.46%
2,791 $103,000
Q4 2021

Feb 14, 2022
BUY
$25.61 - $35.1 $40,028 - $54,861
1,563 Added 125.95%
2,804 $86,000
Q3 2021

Nov 12, 2021
BUY
$33.54 - $40.55 $12,510 - $15,125
373 Added 42.97%
1,241 $42,000
Q2 2021

Aug 17, 2021
BUY
$34.54 - $47.25 $29,980 - $41,013
868 New
868 $35,000

Others Institutions Holding IONS

# of Institutions
402
Shares Held
136M
Call Options Held
862K
Put Options Held
582K
View Full List

About IONIS PHARMACEUTICALS INC

IONS Quotes by TradingView
  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.16B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Itau Unibanco Holding S.A. Portfolio

Follow Itau Unibanco Holding S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Itau Unibanco Holding S.A., based on Form 13F filings with the SEC.

News

Stay updated on Itau Unibanco Holding S.A. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email